Inipharm
PrivateLast Round
Series A
Nov 11, 2020
Total Funding Raised
$35M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Inipharm is a biopharmaceutical company specializing in the discovery and development of small-molecule therapies for severe liver diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inipharm Comparables
Compare Inipharm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hepion Pharmaceuticals Inc | 78% | |
| Nula Therapeutics | 76% | |
| Arrowhead Pharmaceuticals | 73% | |
Inipharm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 11, 2020 |
Inipharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Frazier Healthcare Partners | Series A |
| Wu Capital | Series A |
| 5AM Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors grew 37% MoM.
Inipharm Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Inipharm's valuation, stock price, and market status.